Drug discovery in academia: the third way?

As the pharmaceutical industry continues to re-strategise and focus on low-risk, relatively short-term gains for the sake of survival, we need to re-invigorate the early stages of drug discovery and rebalance efforts towards novel modes of action therapeutics and neglected genetic and tropical diseases. Academic drug discovery is one model which offers the promise of new approaches and an alternative organisational culture for drug discovery as it attempts to apply academic innovation and thought processes to the challenge of discovering drugs in addressing real unmet need.